---
title: "Breast Implant Illness: Symptoms, Evidence and Treatment in 2026"
url: https://drturner.com.au/blogs/latest-update-on-breast-implant-illness-symptoms-and-treatment/
date: 2022-03-17
modified: 2026-07-31
author: "Dr Scott J Turner"
description: "Dr Scott J Turner | Specialist Plastic Surgeon (FRACS) Key Takeaways Breast implant illness describes a cluster of systemic symptoms some patients experience after augmentation and attribute to their implants...."
categories:
  - "Breast Implants"
tags:
  - "breast implant illness"
  - "breast implant illness Sydney"
  - "breast implant illness symptoms checklist"
  - "Breast Implants"
  - "Dr Scott Turner"
  - "Dr Scott Turner Sydney"
image: https://drturner.com.au/wp-content/uploads/2024/04/blogplaceholder-img.svg
word_count: 2128
---

# Breast Implant Illness: Symptoms, Evidence and Treatment in 2026

*[Dr Scott J Turner](https://drturner.com.au/dr-scott-turner-sydney-plastic-surgeon/) | Specialist Plastic Surgeon (FRACS)*

> **Key Takeaways**
>
>
>
>
> - Breast implant illness describes a cluster of systemic symptoms some patients experience after augmentation and attribute to their implants. The symptoms are real; the mechanism is still being worked out.
> - It is not yet a discrete medical diagnosis with a specific cause and a specific test, but it is taken seriously, and both the FDA and the TGA now reference it in their patient information.
> - The symptom list is broad and non-specific, which is part of why it has been difficult to characterise. What is distinctive is the cluster pattern, the timing relative to surgery, and the reported improvement after removal.
> - Explant is the intervention with the most consistent reported improvement, though improvement is not universal and cannot be predicted for an individual.
> - A thorough medical workup comes first. A meaningful proportion of patients have a different, treatable explanation, and identifying or excluding that before surgery is part of good practice.
> - The evidence does not establish en-bloc capsulectomy as better than partial capsulectomy for symptom improvement. The surgical approach should be a clinical decision, not one driven by patient forums.
Breast implant illness is one of the most contested topics in modern breast surgery. On one side, patients report a constellation of symptoms they attribute to their implants, often improving after removal. On the other, the medical literature has been slow to accept it as a discrete diagnosis, because the symptom list is broad, the proposed mechanism is uncertain, and rigorous controlled studies are hard to design. Both positions are honest, and the reasonable view sits between them: the symptoms are real, the mechanism is still being worked out, the explant data is genuinely promising, and the conversation has moved well beyond the dismissive framing of a decade ago.

This guide covers what is currently understood in 2026: symptom patterns, the evidence on causes, the role of explant, and how a consultation should look. The surgical pathway is on the [breast implant revision and removal](https://drturner.com.au/procedures/breast-body/breast-implant-revision/) page, and this post sits within the broader account of [breast augmentation risks and complications](https://drturner.com.au/blogs/breast-augmentation-risks-complications/). The most important thing, if you are worried, is to have the conversation with a surgeon who takes it seriously.

## What breast implant illness is

Breast implant illness refers to a group of systemic symptoms some patients experience after implant surgery and attribute to the implants. The symptoms vary substantially, but commonly reported features include fatigue, cognitive difficulty, joint and muscle pain, hair changes, skin rashes, gastrointestinal issues, and a general sense of being unwell.

On the current state of evidence: it is not yet recognised as a discrete medical diagnosis with a specific cause and a specific test. It is recognised in the broader medical community as a phenomenon that deserves serious attention, and both the FDA in the United States and the TGA in Australia now reference it directly in their patient information about breast implants. That is a meaningful shift from where the conversation sat even five years ago. The recognition that something real is happening to a subset of patients, even without a unified explanation, is the foundation for taking it seriously in practice.

It helps to understand why the diagnostic status is unsettled rather than simply reading it as scepticism. A formal diagnosis usually rests on a defining feature: a specific test result, a characteristic finding, or a symptom pattern seen consistently enough to be codified. Breast implant illness does not yet have any of those, because the symptoms overlap heavily with common conditions, no test distinguishes it, and the studies that would settle the question are difficult to run well, since the honest comparison would require following large matched groups of women with and without implants over many years. The absence of a codified diagnosis is therefore a statement about the evidence, not a judgement that the symptoms are imagined. Good clinical practice treats the symptoms as real and investigates them properly while the research continues to develop.

## Recognised symptom patterns

The symptoms most commonly reported cluster into a few broad categories, and patients rarely have all of them; most have a personal cluster of perhaps five to ten that affect them most.

Constitutional symptoms are the most commonly reported, including persistent fatigue often described as different from ordinary tiredness, cognitive difficulty, sleep disturbance and a generalised sense of being unwell. Musculoskeletal symptoms include joint pain, muscle pain and morning stiffness, which can resemble early inflammatory arthritis and are one reason patients sometimes receive other diagnoses first. Skin and hair changes include unexplained rashes, hair thinning and skin sensitivity. Neurological and psychological symptoms include headaches, anxiety or low mood disproportionate to circumstances, and concentration difficulty. Other reported symptoms include gastrointestinal issues, dry eyes, new food sensitivities, hormonal disturbance and recurrent infections.

The non-specific nature of this list is part of why the condition has been difficult to characterise, since each individual symptom has many possible causes. What makes the pattern distinctive is the cluster, the timing relative to implant surgery (sometimes immediate, often delayed by years), and the reported improvement after removal.

## What is known about causes

The honest answer is that it is not fully known, and the picture is likely multifactorial rather than a single mechanism.

An immune or inflammatory response to the implant materials or the surrounding capsule has been proposed, consistent with a framework some researchers describe as autoimmune syndrome induced by adjuvants, which remains contested in the literature. Low-grade bacterial colonisation of the implant surface, or biofilm, has been investigated as a possible contributor, with evidence still developing. Whether implant surface or texture plays a separate role is less well established, though it has been proposed. And individual susceptibility, whether genetic, immunological or otherwise, may help explain why most patients have no systemic symptoms after augmentation while a smaller subset develop the pattern.

What is worth being clear about is that many historical claims about causes have not held up to scrutiny, so speculation about specific factors should be weighed cautiously and should not drive clinical decisions on its own.

## The role of explant

Removing the implants is the intervention that has shown the most consistent improvement across the available studies. Reported rates of improvement vary widely between studies but consistently show meaningful improvement in a substantial proportion of patients.

The pattern of improvement is worth setting out honestly, because it shapes what to expect. Some patients report improvement within days to weeks, which is faster than a purely immune mechanism would predict and has led some researchers to consider whether expectation and the resolution of anxiety play a part alongside any physical change. Others improve gradually over several months. A smaller group notice little change, and for them the workup that preceded surgery matters, because it is what identifies whether an alternative and treatable cause was present all along. None of this means the improvement reported by the majority is not real; it means the response is variable and cannot be promised to an individual, and a surgeon who guarantees resolution is overstating what the evidence supports.

On surgical approach, the evidence for the technique is more nuanced than patient communities sometimes suggest. Earlier suggestions that en-bloc capsulectomy produced greater improvement than less extensive capsule removal have not been clearly supported in subsequent studies, and both approaches have shown improvement. The choice depends on individual factors including capsule thickness, evidence of capsular pathology, implant integrity and patient preference, and it is a conversation to have with your surgeon rather than a decision to make from a forum. The terminology and the technical detail are covered in the [en-bloc and capsulectomy guide](https://drturner.com.au/blogs/patient-safety-advisory-breast-implant-removal-and-capsulectomy/), and the recovery side in [recovery after breast implant removal](https://drturner.com.au/blogs/recovery-after-breast-implant-removal-procedure/).

## When the symptoms are not breast implant illness

A meaningful proportion of patients who present with concerns actually have a different explanation, including identifiable implant complications and unrelated medical conditions.

Capsular contracture, the thickened and sometimes painful scar tissue around an implant, can cause breast pain and distortion that may be misattributed to systemic illness; its presentation and grading are covered in the [capsular contracture guide](https://drturner.com.au/blogs/what-is-capsular-contracture-and-how-can-it-be-treated/). Silent rupture of a silicone implant can cause local symptoms and, in some patients, systemic responses, and is detectable on MRI, which is one reason imaging surveillance is recommended. BIA-ALCL, a rare cancer linked to certain textured implants, typically presents with a delayed seroma rather than the systemic symptom pattern, and is covered in the [BIA-ALCL guide](https://drturner.com.au/blogs/bia-alcl-symptoms-diagnosis-and-treatment-of-breast-implant-associated-lymphoma/).

Unrelated conditions with overlapping symptoms include autoimmune diseases such as rheumatoid arthritis or lupus, thyroid dysfunction, fibromyalgia, chronic fatigue syndrome, the perimenopausal transition, and depression with physical features. A thorough medical workup before attributing symptoms to the implants is important, and some patients with persistent unexplained symptoms benefit from assessment by a rheumatologist, endocrinologist or other specialist before considering removal.

## What to do if you are concerned

If you have implants and symptoms you are worried about, the practical steps are these.

Start with your GP. A general workup, including blood tests for inflammatory markers, thyroid function, hormonal status and vitamin levels, and screening for autoimmune conditions, can identify alternative explanations and provides a baseline. Get appropriate imaging: MRI is the most reliable test for silent rupture in silicone implants, ultrasound can identify capsular issues and seromas, and mammographic screening should continue at the recommended interval. Then book a consultation with a Specialist Plastic Surgeon experienced in implant assessment, which should cover your symptom timeline, a physical examination, a review of your imaging, and a frank discussion of options including removal if that is what you decide is right.

What a good consultation will not include is pressure to decide quickly, dismissal of your symptoms, or a specific procedure being recommended before a full assessment. If a consultation feels like any of those, seek a second opinion.

## The Australian Breast Device Registry

Australia maintains the Australian Breast Device Registry, which tracks implant surgeries, complications and outcomes nationally. If you have had implant surgery here in recent years, your data may be in it, and it is one of the mechanisms by which patterns of implant-related issues, including emerging concerns, are identified over time. If you are considering removal and want your case to contribute to the evolving evidence base, you can ask your surgeon whether your procedure will be entered.

## Frequently asked questions

**Should I get my implants removed if I have these symptoms?**

Not necessarily. The first step is a thorough workup to identify or exclude alternative explanations, since many patients with symptoms initially attributed to the implants have a different, treatable underlying cause. If alternatives are excluded and the symptoms continue to affect quality of life, removal is a reasonable consideration to discuss with a Specialist Plastic Surgeon experienced in this area.

**Does it matter what kind of implants I have?**

The macrotextured implants linked to BIA-ALCL are no longer available in Australia. For breast implant illness specifically, the role of implant type is less clear. Smooth and microtextured silicone implants remain in widespread use and are not currently identified as carrying a significantly different risk than other types. Your surgeon can confirm what you have from your surgical records.

**Will my symptoms definitely improve after explant?**

This cannot be predicted with certainty for any individual. The available evidence suggests a substantial proportion of patients experience meaningful improvement, but it is not universal: some see significant improvement within weeks, others partial improvement over months, and a smaller proportion no meaningful change. That uncertainty is part of an honest informed-consent conversation.

**Do I need an en-bloc capsulectomy, or is partial capsulectomy enough?**

The clinical evidence does not clearly support en-bloc as better than less extensive capsulectomy for symptom improvement. The technique should be tailored to your situation, taking in capsule thickness, implant integrity and other clinical factors. Patient communities sometimes advocate strongly for en-bloc, but the choice should be a clinical decision made with your surgeon based on what your case requires.

**Will Medicare cover removal for breast implant illness?**

Symptoms alone, without a coexisting physical finding, are not a listed indication under the current MBS criteria. Many patients who attribute symptoms to breast implant illness also have a physical finding such as capsular contracture or confirmed rupture that does meet the criteria, in which case Medicare may apply. The eligibility detail is covered in the [Medicare and breast implant removal guide](https://drturner.com.au/blogs/will-medicare-cover-my-breast-implant-removal/).

Dr Scott J Turner is a Specialist Plastic Surgeon (FRACS). A GP referral is required before an initial surgical consultation under the current Medical Board of Australia framework, and it is also valuable here because it carries your medical history and any workup done so far. If you want to discuss your symptoms with a surgeon who takes the topic seriously, [contact the practice](https://drturner.com.au/contact-us/) to arrange a consultation.